Results 171 to 180 of about 67,096 (237)

Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. [PDF]

Mol Cancer Ther
Williams KB, Larsson AT, Keller BJ, Chaney KE, Williams RL, Bhunia MM, Draper GM, Jubenville TA, Hudson WA, Georg GI, Moertel CL, Ratner N, Largaespada DA.   +12 more
europepmc   +1 more source

Preimplantation genetic testing for neurofibromatosis type 1: molecular genetic aspects and impact on reproductive counseling. [PDF]

Hum Reprod
Vernimmen V, De Rycke M, Moutou C, Dreesen J, Blok MJ, van Minkelen R, Lauer-Zillhardt J, Verdyck P, Keymolen K, van Uum C, Homminga I, Brandts L, Stumpel CTRM, Coonen E, Heijligers M, van Zelst-Stams W, Zamani Esteki M, van den Wijngaard A, de Die-Smulders CEM, Paulussen ADC.   +19 more
europepmc   +1 more source

NF1 Gene Rearrangement [PDF]

, 2020
openaire   +1 more source

Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer. [PDF]

Signal Transduct Target Ther
Lim JH, Mun SJ, Kang HM, Yu WD, Oh SJ, Lee JY, Son YS, Lee S, Kim DS, Lee J, Kim SJ, Cho HS, Son MJ, Son MY, Jung CR.   +14 more
europepmc   +1 more source

Variant Resolution Through RNA Testing and Affected Tissue Analysis in the Neurofibromatoses: A Case Series. [PDF]

Neurol Genet
Schatz KS, Applegate CD, Belzberg AJ, Chen Y, Romo CG, Slobogean B, Blakeley J, Dimachkie MM.   +7 more
europepmc   +1 more source

Duodenal ampullary neuroendocrine tumor, high risk gastrointestinal stromal tumor, and gastric leiomyoma in a patient with neurofibromatosis type 1: a rare case report and literature review. [PDF]

Front Oncol
Yin X, Yang H, Yin Y, Zhang B.
europepmc   +1 more source

NF1 Gene Mutation [PDF]

, 2020
openaire   +1 more source

Clinical and Humanistic Burden Among Adults with Neurofibromatosis Type 1 and Symptomatic Plexiform Neurofibroma in the United States. [PDF]

Neurol Ther
Yang X, Done N, Cunnington M, Gao Y, Dettling T, Pfefferkorn J, Young-Xu L, Duh MS, Wolters PL.   +8 more
europepmc   +1 more source

Impaired Bone Healing and Fracture Complications during Limb Lengthening in a Neurofibromatosis Type 1 Patient Receiving Selumetinib: Case Report and Literature Review. [PDF]

J Orthop Case Rep
Safari Z, Tirta M, Rahbek O, Kold S.
europepmc   +1 more source

Healthcare utilization patterns and costs related to neurofibromatosis 1 in Ontario, Canada. [PDF]

Orphanet J Rare Dis
Sivadasan A, Hernandez A, Candido E, Parkin PC, Tu K, Mendoza M, Barnett-Tapia C.   +6 more
europepmc   +1 more source